DK130978C - - Google Patents

Info

Publication number
DK130978C
DK130978C DK112873A DK112873A DK130978C DK 130978 C DK130978 C DK 130978C DK 112873 A DK112873 A DK 112873A DK 112873 A DK112873 A DK 112873A DK 130978 C DK130978 C DK 130978C
Authority
DK
Denmark
Application number
DK112873A
Other languages
Danish (da)
Other versions
DK130978B (da
Inventor
P M J Obellianne
P A Carbonnel
G P M H Loiseau
R J Millischer
Original Assignee
Ugine Kuhlmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ugine Kuhlmann filed Critical Ugine Kuhlmann
Publication of DK130978B publication Critical patent/DK130978B/da
Application granted granted Critical
Publication of DK130978C publication Critical patent/DK130978C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK112873AA 1972-03-01 1973-03-01 Analogifremgangsmåde til fremstilling af 2-methylamino-4'-methyl-4-piperazinyl-6-chlor-5-methylthiopyrimidin eller salte deraf. DK130978B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7206981A FR2173746B1 (hu) 1972-03-01 1972-03-01

Publications (2)

Publication Number Publication Date
DK130978B DK130978B (da) 1975-05-12
DK130978C true DK130978C (hu) 1975-10-13

Family

ID=9094373

Family Applications (1)

Application Number Title Priority Date Filing Date
DK112873AA DK130978B (da) 1972-03-01 1973-03-01 Analogifremgangsmåde til fremstilling af 2-methylamino-4'-methyl-4-piperazinyl-6-chlor-5-methylthiopyrimidin eller salte deraf.

Country Status (14)

Country Link
US (1) US3843656A (hu)
JP (1) JPS5416510B2 (hu)
AR (1) AR195597A1 (hu)
BE (1) BE796114A (hu)
CA (1) CA977756A (hu)
CH (1) CH556858A (hu)
DE (1) DE2307536C3 (hu)
DK (1) DK130978B (hu)
ES (1) ES412182A1 (hu)
FR (1) FR2173746B1 (hu)
GB (1) GB1363047A (hu)
NL (1) NL179026C (hu)
NO (1) NO137236C (hu)
SE (1) SE398750B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
NL7605319A (nl) * 1975-05-23 1976-11-25 Mar Pha Etu Expl Marques Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter bereiding van geschikte geneeskrachtige verbindingen.
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
JPS6039175U (ja) * 1983-08-26 1985-03-18 沖電気工業株式会社 発券プリンタのスタツカ装置
DE3417264A1 (de) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine
CA2217034A1 (en) * 1995-04-03 1996-10-10 Sumitomo Pharmaceuticals Company, Limited Novel pyrimidine derivatives effective as psychotropic drug and process for the production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
NO137236C (no) 1978-01-25
NL179026B (nl) 1986-02-03
DE2307536B2 (de) 1979-06-28
NO137236B (no) 1977-10-17
US3843656A (en) 1974-10-22
SE398750B (sv) 1978-01-16
AR195597A1 (es) 1973-10-23
JPS5416510B2 (hu) 1979-06-22
DE2307536A1 (de) 1973-09-13
JPS4899185A (hu) 1973-12-15
ES412182A1 (es) 1976-01-01
DE2307536C3 (de) 1980-03-06
NL7301936A (hu) 1973-09-04
CH556858A (fr) 1974-12-13
FR2173746B1 (hu) 1975-04-25
FR2173746A1 (hu) 1973-10-12
GB1363047A (en) 1974-08-14
CA977756A (en) 1975-11-11
BE796114A (fr) 1973-08-28
DK130978B (da) 1975-05-12
NL179026C (nl) 1986-07-01

Similar Documents

Publication Publication Date Title
DK130978C (hu)
FR2194778B1 (hu)
FR2185512A1 (hu)
FR2169932A1 (hu)
JPS4929535A (hu)
FR2209670A1 (hu)
JPS4897357A (hu)
JPS494476A (hu)
JPS5225958Y2 (hu)
FR2183088B1 (hu)
JPS4991375U (hu)
JPS4955511A (hu)
JPS4932087A (hu)
JPS4896493A (hu)
CH591552A5 (hu)
CH589011A5 (hu)
CH563766A5 (hu)
SE7216678L (hu)
BG17911A1 (hu)
CH580559A5 (hu)
NL7314773A (hu)
CH577916A5 (hu)
CH596325A5 (hu)
CH596324A5 (hu)
NL7311585A (hu)